Publications by authors named "Virginia K Clements"

Claim this Profile
F
Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.
Virginia K Clements, Tiha Long, Ramses Long, Chas Figley, Daniel M C Smith

J Leukoc Biol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles.
Katherine R Adams, Sitara Chauhan, Divya B Patel, Virginia K Clements, Yan Wang

J Proteome Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.
Lucía Geis-Asteggiante, Ashton T Belew, Virginia K Clements, Nathan J Edwards, Suzanne Ostrand-Rosenberg

J Proteome Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD3xPDL1 bi-specific T cell engager (BiTE) simultaneously activates T cells and NKT cells, kills PDL1 tumor cells, and extends the survival of tumor-bearing humanized mice.
Lucas A Horn, Nicholas G Ciavattone, Ryan Atkinson, Netsanet Woldergerima, Julia Wolf, Virginia K Clements

Oncotarget· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice.
Suzanne Ostrand-Rosenberg, Pratima Sinha, Chas Figley, Ramses Long, DoHwan Park, Virginia K Clements

J Leukoc Biol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.
Amy W Ku, Jason B Muhitch, Colin A Powers, Michael Diehl, Minhyung Kim, Virginia K Clements

Elife· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells.
Katherine H Parker, Pratima Sinha, Lucas A Horn, Virginia K Clements, Huan Yang

Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Suzanne Ostrand-Rosenberg, Pratima Sinha, Daniel W Beury, Virginia K Clements

Semin Cancer Biol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
Pratima Sinha, Olesya Chornoguz, Virginia K Clements, Konstantin A Artemenko, Roman A Zubarev

Blood· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.
Minu K Srivastava, Pratima Sinha, Virginia K Clements, Paulo Rodriguez, Suzanne Ostrand-Rosenberg

Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells.
Erica M Hanson, Virginia K Clements, Pratima Sinha, Dan Ilkovitch, Suzanne Ostrand-Rosenberg

J Immunol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.
Stephanie K Bunt, Virginia K Clements, Erica M Hanson, Pratima Sinha, Suzanne Ostrand-Rosenberg

J Leukoc Biol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes.
James A Thompson, Minu K Srivastava, Jacobus J Bosch, Virginia K Clements, Bruce R Ksander

Cancer Immunol Immunother· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.
Stephanie K Bunt, Linglin Yang, Pratima Sinha, Virginia K Clements, Jeff Leips

Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.
Pratima Sinha, Virginia K Clements, Stephanie K Bunt, Steven M Albelda, Suzanne Ostrand-Rosenberg

J Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Pratima Sinha, Virginia K Clements, Amy M Fulton, Suzanne Ostrand-Rosenberg

Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression.
Stephanie K Bunt, Pratima Sinha, Virginia K Clements, Jeff Leips, Suzanne Ostrand-Rosenberg

J Immunol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis.
Pratima Sinha, Virginia K Clements, Suzanne Ostrand-Rosenberg

Cancer Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.
Pratima Sinha, Virginia K Clements, Seth Miller, Suzanne Ostrand-Rosenberg

Cancer Immunol Immunother· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease.
Pratima Sinha, Virginia K Clements, Suzanne Ostrand-Rosenberg

J Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of tumor-specific CD4(+) T lymphocytes by major histocompatibility complex class II tumor cell vaccines: a novel cell-based immunotherapy.
Samudra K Dissanayake, James A Thompson, Jacobus J Bosch, Virginia K Clements, Peter W Chen

Cancer Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease.
Erika A Danna, Pratima Sinha, Mileka Gilbert, Virginia K Clements, Beth A Pulaski

Cancer Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.
Suzanne Ostrand-Rosenberg, Virginia K Clements, Masaki Terabe, Jong Myun Park, Jay A Berzofsky

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis